- AU$24.72m
- AU$26.57m
- AU$11.18m
Annual income statement for Cardiex, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.62 | 5.26 | 4.5 | 4.86 | 11.2 |
| Cost of Revenue | |||||
| Gross Profit | 3.92 | 4.35 | 3.49 | 3.96 | 10.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.81 | 9.97 | 16.1 | 20 | 15.5 |
| Operating Profit | -3.19 | -4.71 | -11.6 | -15.1 | -4.36 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.32 | -5.55 | -11.8 | -18.9 | -6.77 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.32 | -5.55 | -11.8 | -18.9 | -6.77 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.32 | -5.55 | -11.8 | -18.9 | -6.77 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.32 | -5.55 | -11.8 | -18.9 | -6.77 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.043 | -0.056 | -0.103 | -0.13 | -0.034 |